Product Information

SUMATRIPTAN SUCC 100 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.4309 per EA under NDC 69452034672. Its NADAC has been published 215 times since Jul 13, 2022.

FDA first approved this application on Aug 10, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Sumatriptan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for SUMATRIPTAN SUCC 100 MG TABLET has been published 215 times since Jul 13, 2022, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.